2023-03-23 08:43:00 ET
- Palisade Bio press release ( NASDAQ: PALI ): FY GAAP EPS of -$16.53.
- As of December 31, 2022, the Company had cash, cash equivalents and restricted cash of $12.4 million. With the additional net cash proceeds of $4.7 million received in the first week of January ($2.1 million from the Company’s registered direct offering and private placement, which closed on January 4, 2023, plus $2.6 million related to warrant exercises) management believes it has sufficient cash to fund the Company’s operations into mid-2024.
- Shares -1.16% PM.
For further details see:
Palisade Bio GAAP EPS of -$16.53